The nanoparticles, which contained the siRNA, was made of a cyclodextrin-based polymer, a human transferrin protein (TF)-targeting ligand to engage TF receptors on the surface of the cancer cells and a hydrophilic polymer (polyethylene glycol, PEG) used to promote nanoparticle stability in biological fluids. The gene discussed is TF; the disease is cancer.